Evidence map›Paper›PMID 40348791›Full record

ArticleNature communications2025

Designer artificial environments for membrane protein synthesis.

Conary Meyer, Alessandra Arizzi, Tanner Henson, Sharon Aviran, Marjorie L Longo, Aijun Wang, Cheemeng Tan

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Spatially regulated mRNA translation enables functional membrane protein integration in synthetic cells.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Synthetic cells for phage therapy: a perspective.Frontiers in cellular and infection microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Conary Meyer *Department of Biomedical Engineering, University of California, Davis, Davis, CA, 95616, USA.ORCID http://orcid.org/0000-0002-4007-8385
Alessandra Arizzi *Department of Biomedical Engineering, University of California, Davis, Davis, CA, 95616, USA.ORCID http://orcid.org/0009-0004-5664-9615
Tanner HensonDepartment of Biomedical Engineering, University of California, Davis, Davis, CA, 95616, USA.
Sharon AviranDepartment of Biomedical Engineering, University of California, Davis, Davis, CA, 95616, USA.ORCID http://orcid.org/0000-0003-1872-9820
Marjorie L LongoDepartment of Chemical Engineering, University of California, Davis, Davis, CA, 95616, USA.ORCID http://orcid.org/0000-0001-7854-5746
Aijun WangDepartment of Biomedical Engineering, University of California, Davis, Davis, CA, 95616, USA.ORCID http://orcid.org/0000-0002-2985-3627
Cheemeng TanDepartment of Biomedical Engineering, University of California, Davis, Davis, CA, 95616, USA. cmtan@ucdavis.edu.ORCID http://orcid.org/0000-0003-1049-1192

Funding

Engineering and dissecting the synthetic non-dividing-but-active state of hybrid cell-materialsR35GM142788 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Cheemeng Tan · 2021 to 2026
$2.7M
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biologyR01EB034279 · NIBIB · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Randy Carney, Cheemeng Tan · 2023 to 2026
$2.5M
The UC Davis enhanced Molecular, Cellular, and Developmental Biology Training ProgramT32GM153586 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Frederic Louis Chedin, ELVA D DIAZ · 2024 to 2026
$2.3M
NIBIB NIH HHS R01 EB034279NIGMS NIH HHS R35 GM142788NIGMS NIH HHS T32 GM153586U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB) 5R01EB034279U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM142788
6 · The paper itself

Abstract

Protein synthesis in natural cells involves intricate interactions between chemical environments, protein-protein interactions, and protein machinery. Replicating such interactions in artificial and cell-free environments can control the precision of protein synthesis, elucidate complex cellular mechanisms, create synthetic cells, and discover new therapeutics. Yet, creating artificial synthesis environments, particularly for membrane proteins, is challenging due to the poorly defined chemical-protein-lipid interactions. Here, we introduce MEMPLEX (Membrane Protein Learning and Expression), which utilizes machine learning and a fluorescent reporter to rapidly design artificial synthesis environments of membrane proteins. MEMPLEX generates over 20,000 different artificial chemical-protein environments spanning 28 membrane proteins. It captures the interdependent impact of lipid types, chemical environments, chaperone proteins, and protein structures on membrane protein synthesis. As a result, MEMPLEX creates new artificial environments that successfully synthesize membrane proteins of broad interest but previously intractable. In addition, we identify a quantitative metric, based on the hydrophobicity of the membrane-contacting amino acids, that predicts membrane protein synthesis in artificial environments. Our work allows others to rapidly study and resolve the "dark" proteome using predictive generation of artificial chemical-protein environments. Furthermore, the results represent a new frontier in artificial intelligence-guided approaches to creating synthetic environments for protein synthesis.

Indexed as

Membrane ProteinsProtein BiosynthesisHydrophobic and Hydrophilic InteractionsMachine LearningSynthetic BiologyMembrane Proteins

Identifiers

PMID40348791
PMCPMC12065789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.